Gemcitabine and radiotherapy in the treatment of uterine cervical cancer patients at Phramongkutklao Hospital.
Article
in English
| IMSEAR
| ID: sea-41933
ABSTRACT
OBJECTIVES:
To determine response, complication and survival of uterine cervical cancer patients treated with concurrent gemcitabine radiotherapy. MATERIAL ANDMETHOD:
A retrospective review of medical records of 41 patients with uterine cervical cancer patients, stage IIB and above treated with concurrent gemcitabine radiotherapy from August 2000 to August 2003.RESULTS:
At 6 and 12 months of follow up, the complete response rate was 75.6% and 65.9%. The cumulative probability of survival at 6 and 12 months after treatment was 0.93 and 0.85. The main complications were mild hematologic and nonhematologic toxicities.CONCLUSION:
Concurrent gemcitabine radiotherapy provided a satisfactory response in patients with uterine cervical cancer with mild toxicity. Long term follow up data is necessary to determine the recurrent rate of this regimen.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Thailand
/
Aged
/
Female
/
Humans
/
Carcinoma
/
Uterine Cervical Neoplasms
/
Survival Rate
/
Retrospective Studies
/
Treatment Outcome
/
Combined Modality Therapy
Type of study:
Observational study
Country/Region as subject:
Asia
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS